Home > Quotes > SYN

Synthetic Biologics, Inc. Common Stock Quote & Summary Data

SYN 
$2.23
*  
0.06
2.76%
Get SYN Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading SYN now
Exchange: AMEX
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Synthetic Biologics, Inc. Common Stock Intraday Chart




Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 2.26 $ 4.32
Low $ 2.16 $ 0.93

The current last sale of $2.23 is 139.78% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

We are a clinical stage company developing therapeutics to protect the gut microbiome while targeting pathogen-specific diseases. Our lead product candidates in Phase 2 development are: (1) SYN-010, which is intended to reduce the impact of methane-producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation (IBS-C), and (2) SYN-004, which is designed to protect the gut microbiome (gastrointestinal (GI) microflora) from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection (CDI) and antibiotic-associated diarrhea (AAD). In collaboration with Intrexon Corporation, we are also developing preclinical stage monoclonal antibody therapies for the prevention and treatment of pertussis, and novel discovery stage biotherapeutics for the treatment of phenylketonuria (PKU).  ... More ...  

Risk Grade

Where does SYN fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?